Lexeo Therapeutics Inc. C...

2.38
-0.26 (-9.85%)
At close: Apr 04, 2025, 12:17 PM

Lexeo Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
-98.33M -66.39M -59.28M -50.62M -5.15M
2M 1.84M 1.15M 13K n/a
12.47M 3.04M 1.78M 386K n/a
351K 1.66M 2.22M 3.03M 105.83K
-23K 530K 4.5M -2.6M 1.87M
n/a n/a n/a n/a n/a
2.73M 1.48M 1.79M 6.04M 150.15K
-81.15M -59.5M -54.56M -44.18M -3.13M
-481K -165K -901K -188K n/a
n/a n/a n/a n/a n/a
-93.6M n/a n/a n/a n/a
n/a n/a n/a n/a n/a
n/a -50K n/a n/a n/a
-94.08M -165K -901K -188K n/a
-410K 3.58M -163K n/a 2.6M
-17K n/a n/a n/a n/a
n/a n/a n/a n/a n/a
491K -35K 332K -203K -223.59K
88.78M 103.79M 189K 150.86M 32.38M
-86.45M 44.13M -55.27M 106.49M 29.25M
-81.63M -59.66M -55.46M -44.37M -3.13M